BlackRock’s SOPHiA GENETICS SOPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$25.2K Hold
5,086
﹤0.01% 5265
2025
Q4
$23.8K Hold
5,086
﹤0.01% 5187
2025
Q3
$24.2K Buy
5,086
+107
+2% +$368 ﹤0.01% 5114
2025
Q2
$15.4K Hold
4,979
﹤0.01% 5171
2025
Q1
$16.5K Hold
4,979
﹤0.01% 5116
2024
Q4
$15.3K Hold
4,979
﹤0.01% 5135
2024
Q3
$18.2K Hold
4,979
﹤0.01% 4949
2024
Q2
$22.8K Sell
4,979
-293,693
-98% -$1.43M ﹤0.01% 4992
2024
Q1
$1.47M Hold
298,672
﹤0.01% 4096
2023
Q4
$1.41M Hold
298,672
﹤0.01% 4154
2023
Q3
$760K Sell
298,672
-206
-0.1% -$653 ﹤0.01% 4315
2023
Q2
$1.34M Hold
298,878
﹤0.01% 4212
2023
Q1
$1.49M Hold
298,878
﹤0.01% 4188
2022
Q4
$616K Sell
298,878
-103
-0% -$231 ﹤0.01% 4554
2022
Q3
$787K Sell
298,981
-103
-0% -$361 ﹤0.01% 4568
2022
Q2
$1.08M Hold
299,084
﹤0.01% 4504
2022
Q1
$2.31M Sell
299,084
-6,166
-2% -$69.3K ﹤0.01% 4326
2021
Q4
$4.3M Sell
305,250
-1,524
-0.5% -$22.5K ﹤0.01% 4056
2021
Q3
$5.38M Buy
+306,774
New +$5.4M ﹤0.01% 3930

Other funds holding SOPH

BlackRock's SOPH Position: Q1 2026 in Review

BlackRock held its SOPHiA GENETICS (SOPH) position steady in Q1 2026 at 5,086 shares worth $25.2K. The position accounts for ﹤0.01% of the portfolio, ranked #5265.

BlackRock first reported a position in SOPH in Q3 2021 and has held it in 19 quarters since. The position peaked at $5.38M in Q3 2021. 49 funds tracked by Wall St. Rank hold SOPH as of Q1 2026.

  • BlackRock held 5,086 shares of SOPHiA GENETICS worth $25.2K as of Q1 2026.
  • BlackRock left its SOPHiA GENETICS share count unchanged in Q1 2026.
  • SOPHiA GENETICS made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #5265 holding.
  • BlackRock first reported a position in SOPHiA GENETICS in Q3 2021 and has held it in 19 quarters since.
  • BlackRock's SOPHiA GENETICS position peaked at $5.38M in Q3 2021.
  • 49 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.